Cite
MLA Citation
Gurbir Sehmbey et al.. “S3326 Continuation of Mesalamine with Anti-Tumor Necrosis Factor in Inflammatory Bowel Disease: A Two Center Analysis of Treatment Trends and Cost.” American journal of gastroenterology, vol. 116, n.d., pp. S1370–S1371. http://access.bl.uk/ark:/81055/vdc_100144523636.0x000037